Advertisement
Advertisement
Money /
Markets & Investing
Banking & finance
Hong Kong’s anticipated stablecoin licence by end-March does not materialise
Analysts say the delay is most likely administrative and that the overall plan is still on track.
1 Apr 2026 - 8:30AM
videocam
IPO
Hong Kong retains IPO crown but may lose to US mega listings over full year
1 Apr 2026 - 9:28PM
Mainland China
Sketching a recovery: China puts next-gen art buyers in the frame amid slowdown
30 Mar 2026 - 11:51AM
Turkey
As tensions rise, Middle Eastern money and travellers pivot to Hong Kong
Wealthy Gulf visitors are extending their stays in Hong Kong as investors from the region look to hedge risk and tap Asian markets.
29 Mar 2026 - 9:30AM
More Middle Eastern travellers are staying in Hong Kong’s hotels for longer, say hoteliers, in part driven by the US-Israel war on Iran. Photo: Jelly Tse
Banking & finance
Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year
Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.
27 Mar 2026 - 4:52PM
videocam
China’s private sector
China’s obesity drug makers take on global giants as Novo Nordisk patent expires
Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market.
26 Mar 2026 - 11:00AM
Advertisement
Advertisement
Advertisement
China’s private sector
Rights to antibody drug from China’s Keymed change hands in US acquisition
Sichuan-based Keymed expects to receive up to US$320 million as a result of deal involving its autoimmune disease treatment licensed in 2024.
24 Mar 2026 - 4:21PM
Gilead Sciences is one of many drug firms facing a revenue gap owing to expiring patents. Photo: Reuters
Banking & finance
Asian private equity values cash flow as fundraising falls to 12-year low
Advanced manufacturing and healthcare attract more attention at the expense of technology, media and telecommunications, Bain & Co says.
24 Mar 2026 - 9:00AM
Made in China 2025
Global drug giants double down on China amid push for self-reliant supply chains
Multinationals are building self-reliant supply chains in China to insulate local markets from potential trade disruptions, say analysts.
20 Mar 2026 - 2:30PM
Banking & finance
Iran conflict drives fund managers to slash risk and hoard cash: BofA survey
Fund managers pile into cash at fastest pace since Covid-19 as geopolitical tensions, inflation replace AI as top concerns, bank finds.
18 Mar 2026 - 4:40PM
Banking & finance
Chinese banks outpace rivals in Hong Kong wealth growth, Huatai HK CEO says
Booming listings and rising outbound investment demand are accelerating growth for Chinese players, SFC data shows.
18 Mar 2026 - 9:31AM
Wang Lei, CEO of Huatai Financial. Photo: Handout
China’s private sector
US reshoring drive casts shadow over China’s contract drug makers, analyst says
Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.
18 Mar 2026 - 10:10AM
Hong Kong stock market
Hong Kong stocks edge higher as oil steadies, tracking Wall Street gains
Hang Seng Index advances for a second day amid easing concerns over inflation and geopolitical risks.
17 Mar 2026 - 4:46PM
Banking & finance
Hong Kong attracts wave of biotech IPO filings amid AI drug research boom
More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest.
16 Mar 2026 - 2:38PM
China stock market
Hopes of AI monetisation to boost China tech stocks amid war, market scares
Chinese tech stocks prove steadier than regional and US peers, as frenzy over OpenClaw shows a possible way forward, analysts say.
16 Mar 2026 - 8:30AM
People cross the street beneath screens showing stock data in Shanghai on March 9, 2026. Photo: EPA
Biomedicine: Companies
In a first for China, Neuracle’s brain-computer interface wins approval
China’s BCI start-ups, seen as potential rivals to Elon Musk’s Neuralink, gain momentum as regulatory support and new capital fuel growth.
14 Mar 2026 - 12:54AM
Banking & finance
China investors energise Hong Kong biotech stocks. Is foreign money missing out?
Stock Connect reshuffle reflects biotech sector’s growing role on international stage, though overseas funds remain cautious.
10 Mar 2026 - 5:26PM
Advertisement
Advertisement
Advertisement
Millionaires and billionaires
Adrian Cheng maps out investment plan in line with China’s 5-year plan
The former CEO of NWD plans to spend more time in mainland China this year to scope out tech investment targets.
11 Mar 2026 - 5:57PM
Adrian Cheng says he has invested in a Chinese robotics firm. Photo: Handout
Made in China 2025
China biotech outlicensing tops US$52 billion in first 2 months
The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB.
5 Mar 2026 - 11:01AM
Two Sessions 2026
Healthcare investors looking to ‘two sessions’ for clarity on drug pricing
Healthcare and insurance sectors will see policy fine-tuning, ‘moral support’ rather than ‘groundbreaking news’ from Beijing, analysts say.
4 Mar 2026 - 9:05AM
IPO
HSBC chairman floats ‘IPO connect’ for Hong Kong, Shenzhen listings
Modelled on Stock Connect, the proposal would give investors in the Greater Bay Area cross-border access to new share listings.
3 Mar 2026 - 6:43PM
Made in China 2025
Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals
Chinese pharmaceutical firms are poised for profit growth, driven by innovative drug sales and licensing deals, despite pricing pressures.
1 Mar 2026 - 12:00PM
Pills are produced and packed at Modern Pharmaceutical’s factory. Photo: Shutterstock
Hong Kong stock market
The big cornerstone comeback: what’s driving investors back to Hong Kong IPOs?
After four subdued years, the cornerstone investors that anchor Hong Kong’s IPO market are returning in force, reshaping the deal landscape.
28 Feb 2026 - 1:44PM
Mainland China
China’s copper crash: from investment fad to scrap in a month
A brief speculative frenzy amid skyrocketing gold and silver prices leaves some retail investors holding shiny kilogram bars they can’t sell.
26 Feb 2026 - 8:30AM
China stock market
US investors increase buying of Hong Kong, mainland Chinese stocks
American investors bought US$15 billion of Hong Kong and mainland stocks in 2025, as buying picked up steam through the year.
24 Feb 2026 - 5:00PM
Help preserve 120 years of quality journalism.
SUPPORT NOW
